LAUREN INGRAM: Open Payments
NPI 1457729899 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,275 in 130 payments from 17 companies in 2025. Trend: 2023 $2,337 · 2024 $2,272 · 2025 $3,275
Food & beverage: $3,275
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 34 | $1,023 |
| AstraZeneca Pharmaceuticals LP | 17 | $516 |
| Regeneron Healthcare Solutions, Inc. | 11 | $248 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $235 |
| GlaxoSmithKline, LLC. | 10 | $214 |
| Pharming Healthcare, Inc. | 8 | $213 |
| Novartis Pharmaceuticals Corporation | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| BioCryst US Sales Co., LLC | 4 | $104 |
| Organon LLC | 6 | $99 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, FASENRA, RUCONEST, AYVAKIT, NUCALA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
